Items 61 ~ 80 of 5552, Page 4 of 279 
  04/13/2019 WHO - Public Health
At WHO Forum on Medicines, countries and civil society push for greater transparency and fairer prices
- WHO to continue to facilitate countries' information-sharing to improve transparency on prices
  04/11/2019 U.S. FOOD & DRUG ADMINISTRATION - Government
FDA orders important safety labeling changes for Addyi
  04/03/2019 U.S. FOOD & DRUG ADMINISTRATION - Government
Statement on FDA¡¯s continued efforts to stop stem cell clinics and manufacturers from marketing unapproved products that put patients at risk, while progressing the agency¡¯s commitment to help advance legitimate stem cell product development under existing agency regulations
  04/03/2019 U.S. FOOD & DRUG ADMINISTRATION - Government
Statement on FDA¡¯s ongoing scientific investigation of potential safety issue related to seizures reported following e-cigarette use, particularly in youth and young adults
  04/02/2019 U.S. FOOD & DRUG ADMINISTRATION - Government
Statement on steps toward a new, tailored review framework for artificial intelligence-based medical devices
  04/02/2019 Radiological Society of North America - Clinical
Bariatric Embolization Shows Promise in Treatment of Obesity
- Bariatric embolization, a new, minimally invasive treatment for obesity produces weight loss and reduces appetite for up to one year, according to a new study published in the journal Radiology.
  04/01/2019 MERCK - Business
Selumetinib Granted U.S. Breakthrough Therapy Designation in Neurofibromatosis Type 1
- Designation Based on Phase 2 SPRINT Trial in Pediatric Patients with NF1 Plexiform Neurofibromas / Selumetinib Is a MEK 1/2 Inhibitor Being Co-Developed by AstraZeneca and Merck
  03/29/2019 U.S. FOOD & DRUG ADMINISTRATION - Government
FDA approves new oral treatment for multiple sclerosis
  03/27/2019 U.S. FOOD & DRUG ADMINISTRATION - Government
FDA advances landmark policy changes to modernize mammography services and improve their quality
- Proposed rule would require breast density reporting, enhance the FDA¡¯s ability to enforce mammography facilities¡¯ compliance with standards
  03/26/2019 U.S. FOOD & DRUG ADMINISTRATION - Government
FDA approves new oral drug to treat multiple sclerosis

<<  <  [1]  [2]  [3]  [4[5]  [6]  [7]  [8]  [9]  [10]  >  >>
Go to Headlines